176例再生障碍性贫血门诊治疗的真实世界研究
该研究回顾性分析了2018年1月至2019年12月门诊治疗的176例再生障碍性贫血(AA)患者的诊断流程、治疗方案及疗效。结果显示门诊诊断流程中多部位骨穿、PNH克隆筛查、流式免疫分型、染色体核型分析及造血祖细胞培养的完成率均不理想;复诊规律组(每年≥4次)较欠规律组6个月有效率更高、12个月高质量缓解率更好、24个月复发率更低。结论推荐AA门诊患者每年至少复诊4次,并重视完善诊断检查。
要点
- 门诊AA患者诊断流程需重视多部位骨穿、PNH克隆筛查、流式免疫分型、染色体核型分析及造血祖细胞培养。
- 复诊规律(每年≥4次)者6个月有效率52.5%对28.0%,12个月高质量缓解率40.7%对16.7%,24个月复发率4.4%对36.4%。
- 推荐AA门诊治疗患者每年至少复诊4次。
核心结论
- 真实世界门诊AA诊断流程需重视多部位骨穿并完成PNH克隆筛查、流式免疫分型、染色体核型分析及造血祖细胞培养。
- 门诊规律复诊患者更易获得高质量缓解且复发率低,推荐每年至少复诊4次。
研究设计与样本
- 回顾性真实世界研究,纳入2018年1月至2019年12月门诊治疗的176例再生障碍性贫血患者。
- 评估诊断流程、治疗方案及疗效,并按复诊频率分为规律组(每年≥4次,130例)和欠规律组(每年<4次,46例)。
主要发现
- 症状至首次就诊中位时间7(5~120)个月,就诊原因包括出血52.3%、贫血51.7%、感染6.8%。
- 168例(95.5%)完成髂骨骨髓穿刺,仅22例(17.1%)完善多部位骨穿(胸骨分类);骨髓活检完成率85.1%(143/168)。
- 流式免疫分型和染色体核型分析完成率分别为59.5%(100/168)和58.9%(99/168),PNH克隆筛查完成86例(48.5%),造血祖细胞培养完成率最低仅26.8%(45/168)。
- 最常见方案为环孢素A联合雄激素及左旋咪唑77例(43.8%),其次为环孢素A联合雄激素45例(25.6%),单用环孢素A者24例(13.6%),单用雄激素者16例(9.1%),14例(7.9%)选择中药或未治疗。
- 复诊规律组较欠规律组6个月有效率更高(52.5%对28.0%,P=0.005),12个月高质量缓解率更高(40.7%对16.7%,P=0.027),24个月复发率更低(4.4%对36.4%,P=0.001)。
关键数值与推荐
- 推荐AA门诊治疗患者每年至少复诊4次。
- 门诊诊断应重视多部位骨穿并完成PNH克隆筛查、流式免疫分型、染色体核型分析及造血祖细胞培养。
临床怎么用
- 门诊接诊AA患者时应主动评估诊断检查是否完善,尤其多部位骨穿、PNH克隆筛查、流式免疫分型、染色体核型分析及造血祖细胞培养。
- 对门诊AA患者强调规律复诊,每年至少4次,以争取更高缓解率和更低复发率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To explore the diagnostic process and outcomes of patients with aplastic anemia (AA) who received outpatient treatment in a real-world setting. Methods: The diagnostic processes, treatment regimens, and outcomes of 176 patients with AA treated in outpatient centers from January 2018 to December 2019 were reviewed. Results: The median interval from the onset of symptoms to the first visit was 7 (5-120) months. Complaints during the first visit included bleeding (52.3% ) , anemia (51.7% ) , and infection (6.8% ) . For diagnosis, 168 patients (95.5% ) underwent bone marrow aspiration; however, only 22 of them (17.1% ) consented aspiration in multiple sites (sternum) . The completion rate of bone marrow biopsy was 85.1% (143/168) ; flow immunophenotype and karyotype analyses were performed on 59.5% (100/168) and 58.9% (99/168) of AA patients, respectively, and the culture of clonal forming units by bone marrow mononuclear cells was performed on 26.8% (45/168) of AA patients. The most preferred regimen was cyclosporine combined with androgen and levamisole (43.8% , 77 patients) , followed by cyclosporine combined with androgen (25.6% , 45 patients) . Cyclosporine alone was administered in 24 patients (13.6% ) and androgen alone in 16 patients (9.1% ) . Furthermore, 14 patients (7.9% ) did not consent to any drugs or only chose traditional Chinese medicine. The patients were divided according to the frequencies of follow-up: regular follow-up group (≥4 times/year, n=130) and irregular group (<4 times/year, n=46) . The former had a higher 6-month remission rate (52.5% vs 28.0% , P=0.005) , a greater high-quality remission rate in 12 months (40.7% vs 16.7% , P=0.027) , and a lower relapse rate in 24 months (4.4% vs 36.4% , P=0.001) . Conclusion: In real-world settings, bone marrow aspiration in multiple sites should be addressed in outpatient treatment for AA diagnostic work-up, including PNH clone screening, flow immunophenotype, chromosome karyotype analysis, and culture of clonal forming units. Patients with AA who follow regular visits were more likely to achieve high-quality remission and a lower relapse rate. Visits at least four times per year are recommended for AA patients undergoing outpatient treatment. 目的: 探索真实世界门诊治疗再生障碍性贫血(AA)患者的诊断流程、治疗及疗效。 方法: 评估2018年1月至2019年12月门诊治疗176例AA患者的诊断流程、治疗方案及疗效。 结果: 患者出现症状至首次就诊中位时间7(5~120)个月,就诊原因包括出血(52.3%)、贫血(51.7%)、感染(6.8%)。诊断流程中168例(95.5%)患者完成髂骨骨髓穿刺(骨穿),仅22例(17.1%)完善了多部位骨穿(胸骨分类);骨髓活检完成率85.1%(143/168);只有59.5%(100/168)和58.9%(99/168)完成了骨髓流式免疫分型及染色体核型分析;86例(48.5%)完成阵发性睡眠性血红蛋白尿(PNH)克隆筛查;造血祖细胞培养检查完成率最低,仅45例(26.8%)。环孢素A(CsA)联合雄激素及左旋咪唑为最常见治疗方案,总计77例(43.8%),其次为CsA联合雄激素45例(25.6%),单用CsA者24例(13.6%),单用雄激素者16例(9.1%),14例(7.9%)患者确诊后选择中药或未治疗。根据门诊复诊频率将176例患者分为复诊规律组(每年≥4次)130例(73.9%)和复诊欠规律组(每年<4次)46例(26.1%)。复诊规律组6个月有效率较高(52.5%对28.0%,P=0.005),12个月高质量缓解率更好(40.7%对16.7%,P=0.027),24个月复发率更低(4.4%对36.4%,P=0.001)。 结论: 真实世界治疗的AA患者诊断流程需重视多部位骨穿检查并完成PNH克隆筛查、流式免疫分型、染色体核型分析及造血祖细胞培养检查;门诊规律复诊患者可获得高质量缓解,复发率低,推荐每年至少复诊4次。.
引用
- Zhang LL, Yu X, Fang LW, et al. [A real-world study of 176 cases with aplastic anemia treated in outpatient]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 33677870. doi:10.3760/cma.j.issn.0253-2727.2021.01.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。